---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-121932"
form_type: "8-K"
ticker: "CVKD"
cik: "0001937993"
company_name: "Cadrenal Therapeutics, Inc."
filed_at: "2025-12-16T23:59:59+00:00"
generated_at: "2026-05-16T13:06:06.872792+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Cadrenal Therapeutics raises ~$2.2M in registered direct offering and private placement of shares and warrants

## Summary
- Gross proceeds of ~$2.2M from sale of 207,374 shares at $10.85 per share and warrants to purchase 414,748 shares.
- Warrants immediately exercisable at $10.60/share, expire 2 years after effective date of resale registration statement.
- Officers and directors subject to 10-day lock-up; company restricted from equity issuance for 10 days and variable rate transactions for one year.
- Placement agent H.C. Wainwright receives 7% cash fee and 13,479 placement agent warrants at $13.5625/share.
- Closing expected on or about December 16, 2025.

## SEC filing metadata
- accession: 0001213900-25-121932
- form_type: 8-K
- ticker: CVKD
- cik: 0001937993
- company_name: Cadrenal Therapeutics, Inc.
- filed_at: 2025-12-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1937993/000121390025121932/0001213900-25-121932-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1937993/000121390025121932/ea0269824-8k_cadrenal.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-121932
- JSON: https://secwatch.observer/filing/0001213900-25-121932.json
- Plain text: https://secwatch.observer/filing/0001213900-25-121932.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.